Simon McNamara, PhD
Simon joined BresMed in 2021 and has more than 12 years’ experience of working in health economics, health technology assessment (HTA) and strategic pricing. He is an Honorary Research Fellow at the University of Sheffield and holds a PhD in Health Economics, an MSc in Health Economics and an MSc in Behavioural Science.
Prior to becoming a consultant, Simon spent 6 years at Roche in the UK, where he led the Oncology (HER2, Haematology, Signalling) Health Economics and Strategic Pricing team. He has attended over 60 HTA committee and reimbursement meetings, including those with the National Institute for Health and Care Excellence, National Health Service England, the Scottish Medicines Consortium and the National Centre for Pharmacoeconomics.
Simon has an active interest in the development of the HTA methods and has been invited to present his research on this topic at seminars at the University of Oxford, the University of York, the University of Sheffield and the Swedish National Centre for Priority Setting in Health Care.